05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

05/2025

May 28, 2025, 03:50 | Insight
Patrizia Giannatempo: Phase 1/2 Duravelo-1 study
Patrizia Giannatempo, Medical Oncology Consultant at the National Cancer Institute (INT) in Milan, shared a…
May 28, 2025, 03:17 | Blog
Eric Singhi: Looking forward to discussing several of this year’s lung cancer oral abstracts at ASCO25
Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, shared a post on LinkedIn:…
May 28, 2025, 02:52 | Insight
Paolo Tarantino: Five review articles to read be ready for the practice changes in breast oncology expected from ASCO25
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Five review…
May 28, 2025, 02:31 | Blog
Jaume Capdevila: Great discussion on Neuroendocrine Cancer at ASCO25
Jaume Capdevila, Medical Oncologist at Vall d'Hebron University Hospital, shared a post on X: "Have…
May 28, 2025, 00:35 | Blog
Stephen Chun: Special episode of NRG Oncology on LBA results of BR003 for triple negative breast cancer
Stephen Chun, Co-host of the NRG Oncology Podcast, shared a post by NRG Oncology, adding:…
May 27, 2025, 23:34 | Blog
Charu Aggarwal: ASCO25, 4 Days to Go - Pro Tips
Charu Aggarwal, Leslye M. Heisler Professor of Lung Cancer Excellence at at the University of…
May 27, 2025, 22:15 | Blog
The dedication of mentors such as Nazik Hammad is an inspiration to all - AORTIC
AORTIC shared a post by Nazik Hammad, Medical Oncologist and Professor at St. Michael’s Hospital,…
May 27, 2025, 21:32 | Blog
Paolo Tarantino: PATINA Trial and First-Line Options for HR+/HER2+ MBC
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "PATINA tested…
May 27, 2025, 21:28 | Blog
Tingting Zhang: Join to discuss patient partnering in managing chronic toxicities of cancer treatment
Tingting Zhang, Patient Advocate, shared a post by MASCC, adding: "Join us to discuss patient…
May 27, 2025, 17:55 | Opinion
Amol Akhade: DESTINY-Breast09 is One of ASCO 2025’s Most Anticipated Trials
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
All: 2618 Posts: 351 - 360
Special Coverage